Lombard Medical Inc (EVAR)

0.05
0.00 (0.00)
OTC : Health Care
Prev Close 0.05
Open 0.05
Day Low/High 0.05 / 0.05
52 Wk Low/High 0.02 / 0.75
Volume 1.43K
Avg Volume 79.70K
Exchange OTC
Shares Outstanding 27.95M
Market Cap 6.15M
EPS -1.50
P/E Ratio N/A
Div & Yield N.A. (N.A)
Lombard Medical Announces Scientific Presentations On Altura® And Aorfix™ Endovascular Stent Grafts At The 38th Annual Charing Cross International Symposium

Lombard Medical Announces Scientific Presentations On Altura® And Aorfix™ Endovascular Stent Grafts At The 38th Annual Charing Cross International Symposium

Company exhibit to include a 'hands-on' learning center for new Altura Endovascular Stent Graft and Aorfix with the IntelliFlex LP Delivery System

Lombard Medical Provides Update On New Altura® Endovascular Stent Graft Launch

Lombard Medical Provides Update On New Altura® Endovascular Stent Graft Launch

Launch Reference Centers Continue to be Established in the UK and Germany

Lombard Medical Completes First Altura® Endovascular Stent Graft Live Case Physician Training Workshop

Lombard Medical Completes First Altura® Endovascular Stent Graft Live Case Physician Training Workshop

Event Featured Technical Review and Live Case Presentations

Lombard Medical's New Altura® Endovascular Stent Graft To Be Presented At 9th Annual Houston Aortic Symposium

Lombard Medical's New Altura® Endovascular Stent Graft To Be Presented At 9th Annual Houston Aortic Symposium

Dainis Krievins, MD Will Present at Late Breaking AAA Presentation

Lombard Medical Receives NASDAQ Notice Of Bid Price Deficiency

Lombard Medical Receives NASDAQ Notice Of Bid Price Deficiency

No Immediate Effect on Listing - EVAR Has 180 Days to Regain Compliance

Lombard Medical Announces First Commercial Altura® Endovascular Stent Graft Procedure In Germany Following LINC

Lombard Medical Announces First Commercial Altura® Endovascular Stent Graft Procedure In Germany Following LINC

Patient Successfully Treated Using the Revolutionary Altura Endovascular Stent Graft

Lombard Medical Announces First Commercial Altura® Endovascular Stent Graft Procedure

Lombard Medical Announces First Commercial Altura® Endovascular Stent Graft Procedure

Patient Was Successfully Treated Using the Revolutionary Altura Endovascular Stent Graft

Lombard Medical Announces Completion Of Altura® Endovascular Stent Graft Live Case Presentation At The 12th Annual Leipzig Interventional Course (LINC)

Lombard Medical Announces Completion Of Altura® Endovascular Stent Graft Live Case Presentation At The 12th Annual Leipzig Interventional Course (LINC)

First Ever Live Case Presentation Highlighted Revolutionary Product Advantages

Lombard Medical Announces First Ever Altura® Endovascular Stent Graft Live Clinical Case Presentation At The 12th Annual Leipzig Interventional Course (LINC)

Lombard Medical Announces First Ever Altura® Endovascular Stent Graft Live Clinical Case Presentation At The 12th Annual Leipzig Interventional Course (LINC)

Scientific Presentations on Aorfix™ and New Altura Stent Graft Systems Also Scheduled

5 Stocks Under $10 Set to Soar: Must-See Charts

5 Stocks Under $10 Set to Soar: Must-See Charts

These stocks trading for less than $10 a share are within range of triggering breakout trades.

Three-Year Follow-Up Data From Lombard Medical Aorfix(TM) PYTHAGORAS Pivotal Trial Presented At 42nd Annual VEITHsymposium(TM)

Three-Year Follow-Up Data From Lombard Medical Aorfix(TM) PYTHAGORAS Pivotal Trial Presented At 42nd Annual VEITHsymposium(TM)

Longer-Term Positive Outcomes in Abdominal Aortic Aneurysm Patients With Standard and Challenging Anatomies Reinforce the Broad Clinical Value of Aorfix

Lombard Medical Announces Scientific Presentations On Aorfix(TM) And Altura(TM) Endovascular Stent Grafts At The 42nd Annual VEITHsymposium(TM)

Lombard Medical Announces Scientific Presentations On Aorfix(TM) And Altura(TM) Endovascular Stent Grafts At The 42nd Annual VEITHsymposium(TM)

Debut of Data on New IntelliFlex(TM) Delivery System and Early Clinical Experience With Altura

Lombard Medical Announces Positive Results Of First-in-Man Clinical Case Using New Low Profile IntelliFlex(TM) LP Delivery System To Deploy Aorfix(TM) Endovascular Stent Graft

Lombard Medical Announces Positive Results Of First-in-Man Clinical Case Using New Low Profile IntelliFlex(TM) LP Delivery System To Deploy Aorfix(TM) Endovascular Stent Graft

Design Enhances Control and Precision During Placement and Reduces Potential for Vessel Trauma

Lombard Medical Reports 2015 Third Quarter, Nine-Month Results

Lombard Medical Reports 2015 Third Quarter, Nine-Month Results

Year-to-Date Aorfix Revenue Up 43 Percent Year-over-Year; Market Share in Japan Exceeds Five Percent in First Year of Sales

3 Health Services Stocks Pushing The Industry Higher

3 Health Services Stocks Pushing The Industry Higher

TheStreet highlights 3 stocks that pushed the Health Services industry